Celltrion Pharm (068760.KQ) Earnings Analysis

Celltrion Pharm (068760.KQ) has no confirmed upcoming earnings date. Trailing P/E 42.80.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 068760.KQ next report earnings?

No confirmed upcoming earnings date is currently scheduled for 068760.KQ. This page updates as the calendar is published.

068760.KQ earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-16204.56 KRWn/an/an/a
2025-09-30264 KRWn/an/an/a
2025-08-18255.04 KRWn/an/an/a
2025-05-15168.4 KRWn/an/an/a
2025-03-17142.77 KRWn/an/an/a
2024-11-14190.48 KRWn/an/an/a
2024-08-14134.94 KRWn/an/an/a

068760.KQ valuation and analyst view

Trailing P/E42.80
Trailing EPS903.32 KRW
Price / book4.00
Dividend yield0.51%
Market cap1681.81B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Celltrion Pharm (068760.KQ)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for 068760.KQ. This page updates as the calendar is published.

Did 068760.KQ beat earnings last quarter?

Consensus estimate data was not available for 068760.KQ's 2026-03-16 report.

What is 068760.KQ's current P/E ratio and EPS?

068760.KQ trades at a trailing P/E of 42.80 on trailing EPS of 903.3159394918754 KRW.

What do analysts rate 068760.KQ?

068760.KQ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.